OSI.L

Osirium Technologies Plc
Osirium Technologies - Update re proposed grant of options
18th April 2023, 06:00
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 5049W
Osirium Technologies PLC
18 April 2023
 

18 April 2023

 

Osirium Technologies plc

("Osirium", the "Group" or the "Company")

 

Update re proposed grant of options

 

Osirium Technologies plc (AIM: OSI), a leading vendor of cloud-based cybersecurity and IT automation software, provides an update on the proposed amendments to the Company's share option scheme to be considered at its forthcoming AGM, details of which were announced on 3 April 2023 (the "Announcement").

 

The Company has received feedback from certain key shareholders in the Company ("Shareholders") regarding the proposed New Options set out in the Announcement. The Company intends to continue to seek shareholder approval for the amendments to the Company's Enterprise Management Incentive (EMI) Share Option Plan 2020-2025 (the "Plan") at the AGM as set out in the AGM notice. However, Osirium's Remuneration Committee (the "Remuneration Committee") has taken on board the feedback received and has decided to make certain amendments to the New Options proposed to be granted, should the Plan Resolution be passed at the AGM, as follows:

 

·    the New Options will have a minimum exercise price of 2p (being the issue price of the Company's most recent fundraise) or, if higher at the time of grant, the 'Market Price' of an Ordinary Share as determined under the Plan rules;

 

·    all New Options will be subject to the following additional performance based vesting criteria:

the closing share price of an Ordinary Share must exceed 4p for a rolling 30-day period; and

the Company must have achieved annualised recurring revenue ("ARR") of at least £3.5 million, when reported in the Company's full year or half year results.

 

·    The New Options would still vest equally over three years as set out in the Announcement.

 

The Remuneration Committee believes that these additional performance criteria more closely align the targets with the interests of Shareholders. 

 

The Remuneration Committee has also determined that the New Options would only be granted to members of the full-time executive management team and key employees. Therefore, the number of New Options that are proposed to be granted to Directors of the Company and persons closely associated with them ("PCAs") are as follows:

 

Director/PCA

No. of existing options currently held and to be surrendered

No. of New Options to be granted

Percentage of existing issued share capital of the Company represented by the New Options

Stuart McGregor (CEO)

218,500

3,676,461

3.00%

Rupert Hutton (CFO)

147,250

1,225,487

1.00%

David Guyatt (Chairman)

1,061,416

-

-

Simon Lee (NED)

147,250

-

-

Simon Hember (NED)

26,125

-

-

Catherine Jamieson

(wife of David Guyatt)

180,000

612,743

0.50%

 

The Board of Osirium welcomes the opportunity for engagement with Shareholders and would like to thank those Shareholders who provided feedback on the original proposals. Full details of the proposed amendments to the Plan are set out in the explanatory notes to the notice of AGM. Should the Plan Resolution not be passed at the AGM, the Company will not be able to make the proposed amendments to the Plan or grant the New Options. A further announcement will be made on conclusion of the AGM.

 

Definitions

 

Capitalised terms used in this announcement have the meanings given to them in the Announcement issued by the Company on 3 April 2023, unless otherwise defined herein.

 

Contacts:




Osirium Technologies plc

Tel: +44 (0)1183 242 444

Stuart McGregor, Chief Executive Officer


Rupert Hutton, Chief Financial Officer




Allenby Capital Limited (Nominated adviser and broker)

Tel: +44 (0)20 3328 5656

James Reeve / George Payne (Corporate Finance)


Tony Quirke (Sales and Corporate Broking)




Alma PR (Financial PR adviser)

Tel: +44 (0)20 3405 0205

Hilary Buchanan

osirium@almapr.co.uk

Kieran Breheny


Will Ellis Hancock


 

About Osirium Technologies Plc

 

Osirium Technologies plc (AIM: OSI) is a leading UK-based cybersecurity software vendor delivering Privileged Access Management (PAM), Privileged Endpoint Management (PEM) and Osirium Automation solutions that are uniquely simple to deploy and maintain.

 

With privileged credentials involved in over 80% of security breaches, customers rely on Osirium PAM's innovative technology to secure their critical infrastructure by controlling 3rd party access, protecting against insider threats, and demonstrating rigorous compliance. Osirium Automation delivers time and cost savings by automating complex, multi-system processes securely, allowing them to be delegated to Help Desk engineers or end-users and to free up specialist IT resources. The Osirium PEM solution balances security and productivity by removing risky local administrator rights from users, while at the same time allowing escalated privileges for specific applications.

 

Founded in 2008 and with its headquarters in Reading, UK, the Group was admitted to trading on AIM in April 2016. For further information please visit www.osirium.com.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKDLFFXZLEBBE ]]>
TwitterFacebookLinkedIn